Venclexta 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FV433
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,366
Award facts
- Contract value 100% obligated
- $10,366.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,366.08 to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on January 12, 2026, with an ultimate completion date of February 3, 2026. This contract utilizes firm fixed-price pricing with no set-aside designation, indicating the award was made through full and open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 31, 2031.
Venclexta is a specialized oncology medication used in the treatment of certain blood cancers, reflecting the critical pharmaceutical supply needs of the Defense Health Agency and military healthcare systems worldwide. AmerisourceBergen's extensive role as a pharmaceutical prime vendor for the Defense Logistics Agency demonstrates the company's established capability to deliver brand-name specialty medications and other essential medical commodities supporting military treatment facilities and federal healthcare programs. The firm fixed-price structure and competitive award process underscore DLA's confidence in AmerisourceBergen's ability to meet federal procurement requirements for specialized pharmaceutical products at predetermined pricing.
Quick answers
Who was awarded contract SPE2DR26FV433?
SPE2DR26FV433 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV433 worth?
The government has obligated $10,366 on SPE2DR26FV433.
Is contract SPE2DR26FV433 an order under another contract?
Yes. SPE2DR26FV433 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV433 competed?
The extent of competition for SPE2DR26FV433 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award